文献速递免疫规划卫生政策与健康促进

伤寒结合疫苗公共卫生影响与成本效果模型预测的比较

Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness.
PubMed 文献 · Vaccine · 2022-12-29

本研究比较了四个动态模型和一个静态模型,在印度加尔各答年龄别伤寒病例数据基础上,评估三种伤寒结合疫苗接种策略。常规接种在乐观情景下10年减少症状性病例10-46%,悲观情景下2-16%;加单次补种在乐观和悲观情景下分别减少36-90%和6-35%。三个经济分析模型均预测常规接种(±补种)相比不接种具有成本效果。

要点

  • 常规接种在乐观情景下10年减少症状性伤寒病例10-46%,悲观情景下2-16%。
  • 加单次补种在乐观和悲观情景下分别减少36-90%和6-35%。
  • 慢性携带者对传播贡献越大,疫苗影响预测值越低。

核心结论

  • 尽管模型预测的疫苗影响和成本效果存在差异,在加尔各答等高发病率地区,常规接种加单次补种可能具有影响力和成本效果。

研究设计与样本

  • 比较四个动态模型和一个静态伤寒传播与疫苗影响数学模型,所有模型拟合印度加尔各答年龄别伤寒病例的共同数据集。

主要发现

  • 常规接种在乐观情景(初始疫苗效力95%,平均保护期19年)下10年减少症状性病例10-46%,悲观情景(初始效力82%,平均保护期6年)下减少2-16%。
  • 加单次补种(9个月至15岁)在乐观情景下减少发病36-90%,悲观情景下减少6-35%。
  • 疫苗影响预测值随慢性携带者对传播相对贡献增加而降低。
  • 模型A-C均预测常规接种(加或不加补种)相比不接种具有成本效果,ICER为每避免一个DALY 95-789美元。
  • 两个模型预测仅常规接种的ICER高于加补种的ICER。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Models are useful to inform policy decisions on typhoid conjugate vaccine (TCV) deployment in endemic settings. However, methodological choices can influence model-predicted outcomes. To provide robust estimates for the potential public health impact of TCVs that account for structural model differences, we compared four dynamic and one static mathematical model of typhoid transmission and vaccine impact. All models were fitted to a common dataset of age-specific typhoid fever cases in Kolkata, India. We evaluated three TCV strategies: no vaccination, routine vaccination at 9 months of age, and routine vaccination at 9 months with a one-time catch-up campaign (ages 9 months to 15 years). The primary outcome was the predicted percent reduction in symptomatic typhoid cases over 10 years after vaccine introduction. For three models with economic analyses (Models A-C), we also compared the incremental cost-effectiveness ratios (ICERs), calculated as the incremental cost (US$) per disability-adjusted life-year (DALY) averted. Routine vaccination was predicted to reduce symptomatic cases by 10-46 % over a 10-year time horizon under an optimistic scenario (95 % initial vaccine efficacy and 19-year mean duration of protection), and by 2-16 % under a pessimistic scenario (82 % initial efficacy and 6-year mean protection). Adding a catch-up campaign predicted a reduction in incidence of 36-90 % and 6-35 % in the optimistic and pessimistic scenarios, respectively. Vaccine impact was predicted to decrease as the relative contribution of chronic carriers to transmission increased. Models A-C all predicted routine vaccination with or without a catch-up campaign to be cost-effective compared to no vaccination, with ICERs varying from $95-789 per DALY averted; two models predicted the ICER of routine vaccination alone to be greater than with the addition of catch-up campaign. Despite differences in model-predicted vaccine impact and cost-effectiveness, routine vaccination plus a catch-up campaign is likely to be impactful and cost-effective in high incidence settings such as Kolkata.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Burrows H, Antillón M, Gauld JS, et al. Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness. Vaccine. 2022. PMID: 36586741. doi:10.1016/j.vaccine.2022.12.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。